Pharmaceuticals company Sigachi Industries announced Q1FY26 results Revenue: Rs 1,282 million compared to Rs 957 million during Q1FY25, change 33.99%. Gross Profit: Rs 547 million compared to Rs 477 million during Q1FY25, change 14.67%. EBITDA: Rs 241 million compared to Rs 210 million during Q1FY25. EBITDA Margin: 18.79% for Q1FY26. Net Profit/Loss: Rs -1,010 million compared to Rs 128 million during Q1FY25. Amit Raj Sinha, MD & CEO, Sigachi Industries, said: "Q1FY26 has been an emotionally and operationally challenging quarter for us. The tragic incident led to the loss of lives and injuries among our workforce, and we extend our deepest condolences to all affected. Our immediate focus was on supporting families, ensuring medical care, and cooperating fully with authorities. The incident disrupted manufacturing operations, damaged plant infrastructure and inventory, and delayed shipments, impacting revenue and margins. We activated emergency protocols, launched a detailed safety audit, and have initiated phased restoration. While insurance claims have been filed, no deferred income has been accounted for. This event has prompted a comprehensive review of our operational controls and risk governance. Looking ahead, we are committed to a decisive reset, prioritizing safety, accelerating cost improvements, focusing on margin-led portfolios, and rebuilding with global standards, resilience, and transparency. With the lessons behind us and our resolve strengthened, we are confident in our ability to deliver sustainable growth and improve EBITDA margins.” Result PDF